《 大行報告》摩通下調青啤(00168.HK)目標價至56元 評級「增持」
摩根大通發表報告表示,今年將會是青啤(00168.HK)充滿挑戰性的一年,主因新型肺炎導致銷售渠道的人流量顯著下降,而估計該部分已佔青啤銷售額的55%。
至於青啤去年上半年銷售及息稅折舊攤銷前利潤(EBITDA)分別按年升9.2%及19.8%,故對今年上半年而言該基數較高,該行下調青啤2020至2021年度EBITDA預測5%至20%,料其今年銷售及EBITDA分別按年下跌11%及20%,而明年則回升17%及37%,因此目標價由61元相應降至56元,維持「增持」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.